CCL3 derived from TAMs and cancer cells in esophageal squamous cell carcinoma (ESCC) promoted tumor cell migration and invasion via the CCL3-CCR5 axis and the PI3K/Akt and MEK/ERK pathways [351]. Here, MAP2K7 is linked to esophageal squamous cell carcinoma.